LONDON, Aug 4 (Reuters) - London-listed pharmaceutical group Shire said it was seeking to buy U.S. firm Baxalta in a $30 billion all-share deal to create a global specialist in medicines treating rare diseases with sales of $20 billion by 2020.
from Reuters: New Issues News http://ift.tt/1DpQk8V
Tidak ada komentar:
Posting Komentar